search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
| RESEARCH HIGHLIGHTS |


site,” says Wai Leong Tam, a researcher at the A*STAR Genome Institute of Singapore who led the study. “This can prompt oncologists to perform more thorough examinations or imple- ment new treatment regimens for patients.” Lung tumors contain a variety of different


cell types, including a rare subset known as tumor-initiating cells (TICs), or cancer stem cells considered to be key drivers of disease relapse and spread throughout the body. Tam and his A*STAR colleagues teamed up with physicians from two nearby cancer centers in Singapore to identify regulatory microRNAs that are essential for TIC function. The researchers obtained biopsies from


patients diagnosed with non-small cell lung cancer, isolated TICs from the tumors, and then compared the expression pattern of microRNAs


in these cells with those from non-TIC tissue taken from the same patient samples. Tam’s team found a slew of microRNAs


that were either expressed at much higher or lower levels in the TICs. However, they focused in depth on just two, miR-1246 and miR-1290. These microRNAs were the most up-regulated and had never been characterized before. Observations and experiments showed that both play a critical role in helping seed new tumors at distant sites outside the lungs. The researchers tracked the levels of miR-


1246 and miR-1290 in patients undergoing therapy. “As expected, the higher expression levels of those two microRNAs in malignant tissues consistently predicted poorer survival outcomes in a large cohort of lung cancer patients,” says Wencai Zhang, who worked on


the study as a research scientist at A*STAR, prior to moving to his current position as a research fellow at Harvard Medical School in the United States. The microRNAs could serve as a useful pre-


dictive biomarker of expected patient outcomes. They might also provide promising drug targets. The researchers wiped out the microRNAs with a special kind of drug known as a locked nucleic acid in mouse models and saw reduced tumor growth. The same kinds of drugs are now being used in humans for other diseases, and could prove helpful in treating lung cancer.


1. Zhang, W. C., Chin, T. M., Yang, H., Nga, M. E., Lunny, D. P. et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nature Communications 7, 11702 (2016).


Materials TESTING THE WATER


THEORETICAL MODEL REVEALS HOW DROPLETS GROW AROUND TINY PARTICLES ON A SURFACE


A mathematical model that predicts how water condenses around tiny particles could help to improve chemical industrial processes, including the production of drug tablets, fertilizers and catalysts1. Previous condensation models differ in their rate predictions, depending on


0s 20s


factors such as the shape and composition of the surface that the droplet grows on. Fong Yew Leong of the A*STAR Institute of High Performance Computing wanted to develop a more realistic theoretical model to help his collaborators understand their experimental condensation results. “This


50s 2µm Water droplets grew around clusters of silica particles, rather than forming standalone droplets on the surface. www.astar-research.com


is where modeling and computation gets really useful, in providing physical insights that can’t be obtained from experiments,” says Leong. He and his colleagues modeled a water


droplet growing in the crevice between a micrometer-sized particle and a flat surface. Their model considers factors such as particle size, the surface tension of the droplet, and how much the underlying surface attracts or repels water. The model shows, for example, that a


growing droplet covers a water-attracting (hydrophilic) surface more quickly than a water-repelling (hydrophobic) surface. The volume of a droplet initially increases more slowly on a hydrophobic surface, but then speeds up as the droplet becomes more convex. "The droplet doesn't shrink during condensation; it instead wets the particle completely," says Leong. The team carried out experiments to test


their model, filming how water condensed around micron-sized silicon dioxide particles on a glass slide (see image). They saw that water always condensed in the crevice between a particle and the slide, rather than forming standalone droplets on the surface, and found that the droplets’ growth was almost the same as that predicted by their model. The researchers also adapted the model


A*STAR RESEARCH 39


Adapted from Ref. 1 via CC-BY-4.0 (https://creativecommons.org/licenses/by/4.0/) © T. S. B. Quang et al.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56